ClinicalTrials.Veeva

Menu

NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities (NAV-Kidney)

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status

Not yet enrolling

Conditions

Chronic Kidney Diseases
Kidney Diseases

Treatments

Other: Standard Care
Other: Navigate-Kidney CHW

Study type

Interventional

Funder types

Other

Identifiers

NCT06810622
23-2014

Details and patient eligibility

About

The overarching goal of this project is to refine and adapt previous work on the NAVIGATE-Kidney project for Latinx with CKD. The investigators hypothesize that the multilevel NAVIGATE-Kidney program intervention will reduce the rate of central venous catheter use at KRT start (primary outcome), increase the rate of optimal KRT starts (secondary outcome), increase patient activation, and reduce decisional conflict (patient-centered outcomes) for Latinx with advanced CKD. The project will have four (4) aims.

Full description

The overarching goal of this project is to eliminate structural racism and reduce kidney health disparities faced by Latinx (gender-inclusive term; includes Hispanics, Latino/a/x) individuals. The team developed Navigate-Kidney, a community health worker (CHW) intervention to improve clinical and person-centered outcomes for Latinx with kidney failure receiving maintenance hemodialysis. The investigators now aim to test NAVIGATE-Kidney among individuals with advanced CKD stage 4/5. The investigators hypothesize that compared to standard care, the multilevel NAVIGATE-Kidney intervention will reduce the composite endpoint, defined as (1) time to transition to KRT and central venous catheter use or (2) death (primary outcome), increase the rate of optimal KRT starts and optimal KRT process measures (secondary clinical outcomes), increase patient activation, reduce social challenges, and reduce decisional conflict (patient-centered outcomes) for Latinx with advanced CKD stage 4/5 (eGFR 15-29 mL/min/1.73m2). The investigators will also evaluate Navigate-Kidney implementation outcomes using the PRISM (Practical Robust Implementation and Sustainable Model) science framework and conduct an economic evaluation to inform policy change.

Enrollment

450 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults ≥ 18 years of age,
  • Adults who self-identify as Latino/e/a/x and/or Hispanic,
  • Adults who are not pregnant,
  • Adults who are not incarcerated,
  • Adults who have advanced kidney disease with an eGFR of 15-29 mL/min/1.73m2). No other measures are used to identify eligible patients.

Exclusion criteria

  • Anyone who does not meet the criteria outlined above.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

450 participants in 2 patient groups

NAVIGATE-Kidney CHW
Other group
Description:
A CHW will provide support during visits every 2 weeks for 3 months (i.e., 6 visits during first 3 months) followed by monthly visits until end of study or until 3 months following KRT start.
Treatment:
Other: Navigate-Kidney CHW
NAVIGATE-Kidney Control
Other group
Description:
Participants will receive standard medical care following diagnosis. This care will include educational materials developed that describe prevention of CKD progression, KRT options, and conservative management in English or Spanish.
Treatment:
Other: Standard Care

Trial contacts and locations

2

Loading...

Central trial contact

Lilia Cervantes, MD; Sandra Hernandez, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems